Filing Details

Accession Number:
0001127602-20-019149
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-08 17:25:06
Reporting Period:
2020-06-05
Accepted Time:
2020-06-08 17:25:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652949 Wilfredo Ruiz-Caban C/O Conmed Corporation
525 French Road
Utica NY 13502
Evp Qa, Ra And Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-05 23,360 $39.87 25,592 No 4 M Direct
Common Stock Disposition 2020-06-05 16,555 $81.29 9,037 No 4 F Direct
Common Stock Acquisiton 2020-06-05 18,000 $41.93 27,037 No 4 M Direct
Common Stock Disposition 2020-06-05 13,167 $81.03 13,870 No 4 F Direct
Common Stock Disposition 2020-06-05 9,919 $82.02 3,951 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2020-06-05 23,360 $0.00 23,360 $39.87
Common Stock Options To Purchase Common Stock Disposition 2020-06-05 18,000 $0.00 18,000 $41.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,840 2026-03-01 No 4 M Direct
12,000 2027-03-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.56 to $82.74. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  2. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period